Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ghrelin in gestational diabetes: serum level and mRNA expression in fat and placental tissue.
Telejko B, Kuzmicki M, Zonenberg A, Modzelewska A, Niedziolko-Bagniuk K, Ponurkiewicz A, Wawrusiewicz-Kurylonek N, Nikolajuk A, Szamatowicz J, Laudanski P, Kretowski A, Gorska M. Telejko B, et al. Among authors: modzelewska a. Exp Clin Endocrinol Diabetes. 2010 Feb;118(2):87-92. doi: 10.1055/s-0029-1238313. Epub 2010 Feb 23. Exp Clin Endocrinol Diabetes. 2010. PMID: 20180161
Endothelial dysfunction in Graves' disease.
Popławska-Kita A, Szelachowska M, Modzelewska A, Siewko K, Dzięcioł J, Klimiuk PA, Górska M. Popławska-Kita A, et al. Among authors: modzelewska a. Adv Med Sci. 2013;58(1):31-7. doi: 10.2478/v10039-012-0047-1. Adv Med Sci. 2013. PMID: 23612675
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Free article. Clinical Trial.
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
Rosenstock J, Bajaj HS, Janež A, Silver R, Begtrup K, Hansen MV, Jia T, Goldenberg R; NN1436-4383 Investigators. Rosenstock J, et al. N Engl J Med. 2020 Nov 26;383(22):2107-2116. doi: 10.1056/NEJMoa2022474. Epub 2020 Sep 22. N Engl J Med. 2020. PMID: 32960514 Clinical Trial.
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, Aizenberg D, Wynne AG, Riesmeyer JS, Heine RJ, Wiese RJ; SURPASS-4 Investigators. Del Prato S, et al. Lancet. 2021 Nov 13;398(10313):1811-1824. doi: 10.1016/S0140-6736(21)02188-7. Epub 2021 Oct 18. Lancet. 2021. PMID: 34672967 Clinical Trial.
22 results